Cargando…
Chinese expert consensus on the diagnosis and treatment of hypertension in the elderly (2017)
China has stepped into an aging society. The social service development statistical bulletin 2015 published in July 2016 by Ministry of Civil Affairs showed that till the end of 2015, the amount of people ≥60 years of age had already approached to 222 million, which comprised 16.1% of the Chinese po...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880741/ https://www.ncbi.nlm.nih.gov/pubmed/31942486 http://dx.doi.org/10.1002/agm2.12020 |
_version_ | 1783473822930829312 |
---|---|
author | Liu, Meilin |
author_facet | Liu, Meilin |
author_sort | Liu, Meilin |
collection | PubMed |
description | China has stepped into an aging society. The social service development statistical bulletin 2015 published in July 2016 by Ministry of Civil Affairs showed that till the end of 2015, the amount of people ≥60 years of age had already approached to 222 million, which comprised 16.1% of the Chinese population, while the amount of people ≥65 years of age comprised 10.5% of the Chinese population was 143 million.(1) Hypertension is an independent risk factor for cardio‐cerebral‐vascular diseases and is a primary and contributory cause for death and disability in the elderly. A large number of epidemiological and clinical studies have shown that the risk of target organ damage of hypertension such as ischemic heart disease, cardiac insufficiency, stroke, chronic kidney disease, and aortic and peripheral artery diseases significantly increases with aging. Blood pressure control plays a significant role in reducing cardio‐cerebral‐vascular events and all‐cause mortality.(2) Compared to younger patients with similar blood pressure elevation, the risks of cardiovascular and cerebrovascular events significantly increase in the elderly. Because of specialties in the pathogenesis and clinical manifestation in older patients with hypertension, physicians should pay more attention to the population characteristics and individual treatments. |
format | Online Article Text |
id | pubmed-6880741 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68807412020-01-15 Chinese expert consensus on the diagnosis and treatment of hypertension in the elderly (2017) Liu, Meilin Aging Med (Milton) Guidelines and Consensus China has stepped into an aging society. The social service development statistical bulletin 2015 published in July 2016 by Ministry of Civil Affairs showed that till the end of 2015, the amount of people ≥60 years of age had already approached to 222 million, which comprised 16.1% of the Chinese population, while the amount of people ≥65 years of age comprised 10.5% of the Chinese population was 143 million.(1) Hypertension is an independent risk factor for cardio‐cerebral‐vascular diseases and is a primary and contributory cause for death and disability in the elderly. A large number of epidemiological and clinical studies have shown that the risk of target organ damage of hypertension such as ischemic heart disease, cardiac insufficiency, stroke, chronic kidney disease, and aortic and peripheral artery diseases significantly increases with aging. Blood pressure control plays a significant role in reducing cardio‐cerebral‐vascular events and all‐cause mortality.(2) Compared to younger patients with similar blood pressure elevation, the risks of cardiovascular and cerebrovascular events significantly increase in the elderly. Because of specialties in the pathogenesis and clinical manifestation in older patients with hypertension, physicians should pay more attention to the population characteristics and individual treatments. John Wiley and Sons Inc. 2018-06-11 /pmc/articles/PMC6880741/ /pubmed/31942486 http://dx.doi.org/10.1002/agm2.12020 Text en © 2018 The Authors. Aging Medicine published by Beijing Hospital and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Guidelines and Consensus Liu, Meilin Chinese expert consensus on the diagnosis and treatment of hypertension in the elderly (2017) |
title | Chinese expert consensus on the diagnosis and treatment of hypertension in the elderly (2017) |
title_full | Chinese expert consensus on the diagnosis and treatment of hypertension in the elderly (2017) |
title_fullStr | Chinese expert consensus on the diagnosis and treatment of hypertension in the elderly (2017) |
title_full_unstemmed | Chinese expert consensus on the diagnosis and treatment of hypertension in the elderly (2017) |
title_short | Chinese expert consensus on the diagnosis and treatment of hypertension in the elderly (2017) |
title_sort | chinese expert consensus on the diagnosis and treatment of hypertension in the elderly (2017) |
topic | Guidelines and Consensus |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880741/ https://www.ncbi.nlm.nih.gov/pubmed/31942486 http://dx.doi.org/10.1002/agm2.12020 |
work_keys_str_mv | AT liumeilin chineseexpertconsensusonthediagnosisandtreatmentofhypertensionintheelderly2017 AT chineseexpertconsensusonthediagnosisandtreatmentofhypertensionintheelderly2017 |